Clinical trial
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
NCT02718001 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 6, 2015
- Completion date
- April 30, 2033
- Enrollment
- 123 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve regurgitation (degenerative or functional)